Vaxart, Inc. VXRT
Set alert
As of Oct 30, 3:59 PM ET
- YTD
- +20.00%
- 1 year
- +20.00%
- Open
- 0.42
- Prev close
- 0.427
- Mkt cap
- 102.35M
- Vol
- 128.11K
- Avg vol
- 279.97K
- EPS
- 0.17
- P/E
- 2.47
- Div yield
- 0.00%
More statistics
- Low
- 0.39
- High
- 0.43
- Forward P/E
- -1.47
- Beta
- 0.70
- Short ratio
- 11.71
- Inst. own
- 17.80%
- Dividend
- 0.00
- Ex-div date
- Nov 8, 2012
- 50-d avg
- 0.6812
- 200-d avg
- 0.7986
- 1y target
- 4.83
5D chart
Signals (65)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:10 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:10 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:00 PM | 1 day ago |
| SMA: Bullish | Oct 30, 2:20 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 2:20 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:50 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:15 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:35 PM | 1 day ago |
| SMA: Bearish | Oct 30, 11:55 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:50 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:05 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:05 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 11:05 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 11:00 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:50 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:50 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:30 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:25 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:25 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:00 AM | 1 day ago |
| SMA: Bearish | Oct 30, 10:00 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:40 AM | 1 day ago |
| SMA: Bullish | Oct 30, 9:40 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:50 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 11:40 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:40 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 11:00 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:05 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 2 days ago |
| SMA: Bearish | Oct 29, 9:45 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:35 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 12:25 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 28, 10:00 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 9:45 AM | 3 days ago |
| RSI: Oversold | Oct 28, 9:45 AM | 3 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 4 days ago |
| SMA: Bullish | Oct 27, 11:45 AM | 4 days ago |
| SMA: Bearish | Oct 27, 11:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:55 AM | 4 days ago |
| SMA: Bearish | Oct 27, 10:10 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:00 AM | 4 days ago |
News
2 days ago globenewswire.com
Vaxart to Host Stockholder Fireside Chat on November 6 at 4:30 p.m. ET
Company to report third quarter 2026 financial results on November 5 SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company…
3 weeks ago globenewswire.com
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
Second-generation oral mucosal vaccine candidate (VXA-H5-02) induced robust cross-neutralizing antibodies, significantly reduced viral load, and completely protected against lethal clade 2.3.4.4b…
1 month ago marketbeat.com
Vaxart Highlights Oral Vaccine Platform, COVID Trial Progress at H.C. Wainwright Conference
Vaxart OTCMKTS: VXRT Chief Executive Officer Steve Lo outlined the company's oral vaccine platform, its government-funded COVID-19 study and development opportunities in norovirus and influenza…
1 month ago globenewswire.com
Vaxart to Present at the H.C. Wainwright 28th Annual Global Investment Conference
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
2 months ago globenewswire.com
Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
European Patent Office granted Vaxart a new patent, extending intellectual property protection for Vaxart's Norovirus vaccine program through at least 2036 across key European markets European Patent…
2 months ago marketbeat.com
Vaxart Q2 Earnings Call Highlights
Vaxart OTCMKTS: VXRT said it has reported positive 12-month safety data from the 400-participant Sentinel cohort of its Phase II-B COVID-19 vaccine trial and remains on track to disclose top-line…
2 months ago seekingalpha.com
Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript
Vaxart, Inc. (VXRT) Q2 2026 Earnings Call Transcript
3 months ago globenewswire.com
Vaxart to Host Stockholder Fireside Chat on August 7 at 4:30 p.m. ET
Company to report second quarter 2026 financial results on August 6 SOUTH SAN FRANCISCO, Calif., July 30, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company…
3 months ago defenseworld.net
Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now
Vaxart (OTCMKTS:VXRT) held its 2026 Annual Meeting of Stockholders, where investors re-elected the company's full slate of directors, ratified its auditor and rejected the company's non-binding…
3 months ago globenewswire.com
Vaxart to Participate in BTIG Biotechnology Conference 2026
SOUTH SAN FRANCISCO, Calif., July 21, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
3 months ago marketbeat.com
Vaxart Investors Reject Say-on-Pay as CEO Rules Out Reverse Split for Now
Vaxart OTCMKTS: VXRT held its 2026 Annual Meeting of Stockholders, where investors re-elected the company's full slate of directors, ratified its auditor and rejected the company's non-binding…
3 months ago globenewswire.com
Vaxart Announces Results of Annual Meeting of Stockholders
SOUTH SAN FRANCISCO, Calif. , July 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing a range of oral recombinant…
3 months ago globenewswire.com
Vaxart Reports Topline 12-Month Safety Data From the 400-Participant Sentinel Safety Cohort of the Phase 2b Clinical Trial of Its Oral Pill COVID-19 Vaccine
No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reported
4 months ago globenewswire.com
Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements
Company to Appoint Mutually Agreed Upon Independent Director; Forms Stockholder Engagement and Clinical and Regulatory Affairs Committees
4 months ago globenewswire.com
Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company's Highly Qualified Director Nominees on the WHITE Proxy Card TODAY
Details Strategic Actions Taken by the Board to Advance the Company's Pipeline and Drive Value Creation Vaxart's Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of…
4 months ago globenewswire.com
Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
Latest Modification is Important Required Step to Releasing 12-month Data from 400-participant Sentinel Cohort Funding to Advance Data Analysis from More Than 5,000 Trial Participants Ahead of Key…
4 months ago globenewswire.com
Vaxart's Two Newest Independent Directors James Breitmeyer, M.D., Ph.D., and Kevin Finney Send Letter to Shareholders Ahead of 2026 Annual Meeting
Urges Stockholders to Vote “FOR” ALL Six of Vaxart's Director Nominees on the WHITE Proxy Card TODAY Visit Vote.Vaxart.com for Additional Information and Voting Resources SOUTH SAN FRANCISCO, Calif.,…
4 months ago globenewswire.com
Vaxart to Showcase Oral Vaccine Platform and Strategic Vision at BIO 2026 and Taiwan Biotech Forum
SOUTH SAN FRANCISCO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
4 months ago globenewswire.com
Vaxart to Participate in BTIG Infectious Disease Day 2026
SOUTH SAN FRANCISCO, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its…
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
-
1 year ago benzinga.com
Earnings Scheduled For November 13, 2024
Earnings Scheduled For November 13, 2024
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
2 years ago benzinga.com
Earnings Scheduled For March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
-
2 years ago benzinga.com
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
-
3 years ago benzinga.com
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
-
3 years ago benzinga.com
Why Couchbase Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Mobiquity Technologies, Inc. (NASDAQ: MOBQ) shares gained 124% to $0.3325. Mobiquity Technologies launched ElecAlytics, an AI-Powered analytics suite added to its ElecTech platform for…
-
3 years ago benzinga.com
Earnings Scheduled For May 4, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 114 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 337 companies set new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
OnFriday, 143 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 298 companies achieved new lows for the year.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday saw 219 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's session, 107 stocks hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 79 companies reached new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell • Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 413 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 446 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 838 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
During Monday's trading, 528 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 404 stocks made new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 142 companies hit new 52-week lows.